SCHEMBL6928773

SCHEMBL6928773

OCc1cncn1Cc1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.48
CYP11B2 P19099 4/20 0.48
POLB P06746 1/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
PKM P14618 1/20 0.41
KMT2A Q03164 2/20 0.40
CYP19A1 P11511 1/20 0.40
LMNA P02545 1/20 0.40
PDE5A O76074 1/20 0.39
PDE4A P27815 1/20 0.39
PDE1A P54750 1/20 0.39
PDE1B Q01064 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE1C Q14123 1/20 0.39
PDE3A Q14432 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7657123 0.98 CYP11B1 (0.47) CYP11B1CYP11B2POLBALDH1A1MAPT
SCHEMBL6928819 0.85 CYP11B1 (0.40) CYP11B1CYP11B2POLBALDH1A1KMT2A
Hydrochloric Acid SCHEMBL6922961 0.83 MAPT (0.42) CYP11B1CYP11B2ALDH1A1MAPTL3MBTL1
SCHEMBL6929338 0.81 CYP11B1 (0.51) CYP11B1CYP11B2POLBKMT2ACYP19A1
SCHEMBL6923450 0.79 CYP2C19 (0.53) CYP11B1CYP11B2POLBALDH1A1MAPT
SCHEMBL12820668 0.78 CYP11B1 (0.58) CYP11B1CYP11B2ALDH1A1MAPTKMT2A
SCHEMBL3079356 0.77 CYP11B1 (0.71) CYP11B1CYP11B2POLB
SCHEMBL11740436 0.76 ALDH1A1 (0.49) POLBALDH1A1MAPTL3MBTL1KMT2A
SCHEMBL15358333 0.74 CYP11B1 (0.52) CYP11B1CYP11B2POLBKMT2AMEN1
SCHEMBL3924364 0.73 LMNA (0.49) POLBALDH1A1MAPTL3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1188407-C Imidazole derivatives with inhabiting activity to transterasa and preparing method thereof LG CHEMICAL LTD (KR) 2005-02-09 CN disclosed
EP-1045846-B1 IMIDAZOLE DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE AND PROCESS FOR PREPARATION THEREOF LG CHEMICAL LTD (KR) 2003-05-02 EP disclosed
US-6518429-B2 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus LG CHEMICAL, LTD. (KR) 2003-02-11 US disclosed
US-20020137769-A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof LG CHEMICAL LTD. 2002-09-26 US disclosed
US-6268363-B1 ANTITUMOR LG CHEMICAL LTD. (KR) 2001-07-31 US disclosed
CN-1279680-A Imidazole derivatives having farnesyl transferase inhibitory activity and process for producing the same LG CHEMICAL LTD (KR) 2001-01-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137769-A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof FNTA, FNTB, FDPS CYP11B1 74/4885CYP11B2 110/4885POLB 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.